Home>>Signaling Pathways>> Metabolism>> Bile Acids & Microbiome>>Hyocholic Acid

Hyocholic Acid Sale

(Synonyms: 猪胆酸,γ-Muricholic Acid) 目录号 : GC40717

猪胆酸(Hyocholic Acid; γ-Muricholic Acid)是猪和其他哺乳动物的主要胆汁酸,也在胆汁淤积患者的尿液样本中发现。

Hyocholic Acid Chemical Structure

Cas No.:547-75-1

规格 价格 库存 购买数量
10mM (in 1mL DMSO)
¥1,287.00
现货
5mg
¥1,170.00
现货
10mg
¥1,980.00
现货
25mg
¥4,320.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

Description

Hyocholic acid (γ-Muricholic acid) is the major bile acid in pigs and other mammals and is also found in urine samples of patients with cholestasis[1]. Hyocholic acid promotes intracellular glucagon-like peptide-1 (GLP-1) secretion by activating G protein-coupled bile acid receptor (TGR5) and inhibiting farnesoid X receptor (FXR), thereby improving glucose homeostasis[2]. Hyocholic acid can be used as a novel biomarker for metabolic disorders and can resist type 2 diabetes[3].

In vitro, treatment of STC-1 and NCI-H716 cells with hyocholic acid (25, 50 μM) for 24 h upregulated GLP-1 protein secretion and proglucagon gene transcription in cells [4].

In vivo, oral treatment of diabetic mice with hyocholic acid (100 mg/kg) reduced blood glucose levels, increased fasting insulin levels, and upregulated serum GLP-1 levels through TGR5 and FXR signaling in vivo [4]. Oral treatment of nonalcoholic hepatitis mice with hyocholic acid (10, 100 mg/kg) for 16 weeks alleviated hepatic steatosis induced by a high-fat, high-cholesterol (HFHC) diet, reduced the production of lipid peroxides in a dose-dependent manner, and prevented hepatocyte apoptosis[5].

References:
[1] Lundell K, Wikvall K. Species-specific and age-dependent bile acid composition: aspects on CYP8B and CYP4A subfamilies in bile acid biosynthesis[J]. Current drug metabolism, 2008, 9(4): 323-331.
[2] Jia W, Rajani C, Zheng X, et al. Hyocholic acid and glycemic regulation: Comments on ‘Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism’[J]. Journal of Molecular Cell Biology, 2021, 13(6): 460-462.
[3] Zheng X, Chen T, Zhao A, et al. Hyocholic acid species as novel biomarkers for metabolic disorders[J]. Nature communications, 2021, 12(1): 1487.
[4] Zheng X, Chen T, Jiang R, et al. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism[J]. Cell metabolism, 2021, 33(4): 791-803. e7.
[5] Xie Y, Shen F, He Y, et al. Gamma-muricholic acid inhibits nonalcoholic steatohepatitis: Abolishment of steatosis-dependent peroxidative impairment by FXR/SHP/LXRα/FASN signaling[J]. Nutrients, 2023, 15(5): 1255.

猪胆酸(Hyocholic Acid; γ-Muricholic Acid)是猪和其他哺乳动物的主要胆汁酸,也在胆汁淤积患者的尿液样本中发现[1]。Hyocholic Acid通过激活G蛋白偶联胆汁酸受体(TGR5)和抑制法尼醇X受体(FXR)促进细胞内胰高血糖素样肽-1(GLP-1)分泌,改善葡萄糖稳态[2]。Hyocholic Acid可作为代谢紊乱的新型生物标志物,可抵抗2型糖尿病[3]

在体外,Hyocholic Acid(25, 50μM)处理STC-1和NCI-H716细胞24h,上调了细胞中的GLP-1蛋白分泌和胰高血糖素原基因转录[4]

在体内,Hyocholic Acid(100mg/kg)通过口服治疗糖尿病模型小鼠,降低了血糖水平,升高了空腹胰岛素水平,通过体内TGR5和FXR信号传导上调了血清GLP-1水平[4]。Hyocholic Acid(10、100mg/kg)通过口服治疗非酒精性肝炎小鼠16周,可减轻由高脂肪高胆固醇(HFHC)饮食引起的肝脏脂肪变性,剂量依赖性地减少了脂质过氧化物的产生,阻止了肝细胞凋亡过程[5]

实验参考方法

Cell experiment [1]:

Cell lines

STC-1 and NCI-H716 cells

Preparation Method

Cells were treated with different concentrations (5, 25, and 50μM) of Hyocholic Acid with 24h treatment for determination of GLP-1 secretion and proglucagon transcription.

Reaction Conditions

5, 25, 50μM; 24h

Applications

Hyocholic Acid upregulates GLP-1 protein secretion and proglucagon gene transcription in STC-1 and NCI-H716 cells.
Animal experiment [2]:

Animal models

C57BL/6 mice

Preparation Method

C57BL/6 mice were randomized into the normal control (NC), NASH, NASH+vehicle, NASH+10mg/kg Hyocholic Acid, and NASH+100mg/kg Hyocholic Acid groups, respectively. Except for those in the NC group with a normal diet, all the mice were exposed to the high-fat high-cholesterol(HFHC) diet (2% cholesterol, 10% lard, and 88% normal diet) for 16 weeks.

Dosage form

10、100mg/kg; p.o.

Applications

Hyocholic Acid attenuated rodent liver steatosis induced by the HFHC diet. Hyocholic Acid treatment dose-dependently reduced the production of lipid peroxides. Hyocholic Acid treatment dose-dependently prevented hepatocytes from the apoptotic process.

References:

[1]Zheng X, Chen T, Jiang R, et al. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism[J]. Cell metabolism, 2021, 33(4): 791-803. e7.

[2]Xie Y, Shen F, He Y, et al. Gamma-muricholic acid inhibits nonalcoholic steatohepatitis: Abolishment of steatosis-dependent peroxidative impairment by FXR/SHP/LXRα/FASN signaling[J]. Nutrients, 2023, 15(5): 1255.

化学性质

Cas No. 547-75-1 SDF
别名 猪胆酸,γ-Muricholic Acid
化学名 (5β)-3α,6α,7α-trihydroxy-cholan-24-oic acid
Canonical SMILES C[C@H](CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@H](O)[C@H](O)[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@@]21C
分子式 C24H40O5 分子量 408.6
溶解度 30 mg/ml in DMF, 20 mg/ml in DMSO, 20 mg/ml in Ethanol 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 2.4474 mL 12.2369 mL 24.4738 mL
5 mM 0.4895 mL 2.4474 mL 4.8948 mL
10 mM 0.2447 mL 1.2237 mL 2.4474 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置

产品文档

Quality Control & SDS

View current batch: